American Society for Bariatric Surgery. Rationale for the Surgical Treatment of Obesity. Updated April 6, 1998.
Appetite Suppressant. 12 May 2006.
Gastric bypass: Is this weight-loss surgery for you? 17 May 2006.
Gastric Surgery for Severe Obesity. National Institute of Diabetes and Digestive and Kidney Diseases. NIH Publication No. 96-4006, April 1996.
Ioannides-Demos L, Proietto J, et al. Safety of drug therapies used for weight loss and treatment of obesity. Drug Saf. 2006;29(4):277-302.
Kral, J.G. Surgical Treatment of Obesity. In Handbook of Obesity, ed. Bray, G.A., Bouchard, C., James, W.P.T. New York. Marcel Dekker, Inc., 1998.
National Heart, Lung, and Blood Institute. Clinical Guidelines on the Identification, Evaluation, and Treatment of Obesity in Adults: The Evidence Report. NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Obesity in Adults. Washington, DC: U.S. Department of Health and Human Services, 1998
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH). Prescription Medications for the Treatment of Obesity, MSI-WCIN019, Weight-control information network. 2001.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH). Questions About Appetite Suppressant Medication Treatment, MSI-WCIN020, Weight-control information network. 2001.
Obesity Surgery. 17 May 2006.
Shape Up America! American Obesity Association. Guidance for the Treatment of Adult Obesity. Bethesda, MD, revised 1998.
Shekelle P, Morton, S., Maglione M, et al. Ephedra and Ephedrine for Weight Loss and Athletic Performance Enhancement: Clinical Efficacy and Side Effects. Evidence Report/Technology Assessment No. 76, Southern California Evidence-based Practice Center, RAND.
U. S. Food and Drug Administration. FDA Approves Orlistat for Obesity, Food and Drug Administration FDA Talk Paper, April 26, 1999.